Safety and Efficacy Study
Safety and Efficacy of a New Term Infant Formula Supplemented With A Prebiotic: a Doubleblind, Randomized, Controlled Trial
Sponsor: Société des Produits Nestlé (SPN)
Listed as NCT02670863, this NA trial focuses on Infant Term Birth and remains completed. Sponsored by Société des Produits Nestlé (SPN), it has been updated 11 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2023 — Jul 2024 [monthly]
Completed NA
-
Nov 2021 — Mar 2023 [monthly]
Completed NA
Phase: PHASE3 → NA
▶ Show 6 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Aug 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE3
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Société des Produits Nestlé (SPN)
For direct contact, visit the study record on ClinicalTrials.gov .